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Abstract
The healing of a fracture depends largely on the development of a new blood vessel network (angiogenesis) in the callus.
During angiogenesis tip cells lead the developing sprout in response to extracellular signals, amongst which vascular
endothelial growth factor (VEGF) is critical. In order to ensure a correct development of the vasculature, the balance
between stalk and tip cell phenotypes must be tightly controlled, which is primarily achieved by the Dll4-Notch1 signaling
pathway. This study presents a novel multiscale model of osteogenesis and sprouting angiogenesis, incorporating lateral
inhibition of endothelial cells (further denoted MOSAIC model) through Dll4-Notch1 signaling, and applies it to fracture
healing. The MOSAIC model correctly predicted the bone regeneration process and recapitulated many experimentally
observed aspects of tip cell selection: the salt and pepper pattern seen for cell fates, an increased tip cell density due to the
loss of Dll4 and an excessive number of tip cells in high VEGF environments. When VEGF concentration was even further
increased, the MOSAIC model predicted the absence of a vascular network and fracture healing, thereby leading to a non-
union, which is a direct consequence of the mutual inhibition of neighboring cells through Dll4-Notch1 signaling. This result
was not retrieved for a more phenomenological model that only considers extracellular signals for tip cell migration, which
illustrates the importance of implementing the actual signaling pathway rather than phenomenological rules. Finally, the
MOSAIC model demonstrated the importance of a proper criterion for tip cell selection and the need for experimental data
to further explore this. In conclusion, this study demonstrates that the MOSAIC model creates enhanced capabilities for
investigating the influence of molecular mechanisms on angiogenesis and its relation to bone formation in a more
mechanistic way and across different time and spatial scales.
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Introduction
The process of angiogenesis during fracture healing
The biological process of fracture healing comprises three main
stages: (i) the ‘‘inflammation phase’’, where the trauma site
becomes hypoxic and is invaded by inflammatory cells, fibroblasts,
endothelial cells and mesenchymal stem cells [1]; (ii) the
‘‘reparative phase’’, which starts with the production of cartilag-
inous and fibrous tissue resulting in a soft callus, later replaced by a
hard callus, through the process of endochondral ossification; (iii)
in the final ‘‘remodeling phase’’ the woven bone is replaced by
lamellar bone and the vasculature is reorganized.
The healing of a fracture depends largely on the development of
a new blood vessel network (angiogenesis) in the callus. Sprouting
angiogenesis involves the following steps: first a ‘‘tip cell’’ is
selected; this cell extends filopodia sensing the haptotactic and
chemotactic cues in the environment and leads the newly formed
‘‘sprout’’ comprised of following, proliferating ‘‘stalk cells’’; the
newly formed sprout, or ‘‘branch’’ then connects with another
branch in a process called anastomosis, which results in the
formation of a closed loop allowing the initiation of blood flow;
finally the newly formed vascular network is stabilized by pericytes
[2].
In order to ensure a correct development of the vasculature, the
balance between stalk and tip cell phenotypes must be tightly
controlled. The process of tip cell selection consists of the following
main steps. Firstly a gradient of vascular endothelial growth factor
(VEGF) is formed by the up-regulation of VEGF-expression and
secretion, triggered by hypoxia (low oxygen concentration). The
VEGF-mediated activation of the VEGFR-2 receptors induces the
up-regulation of Dll4 which activates the Notch1-receptors on the
neighboring cells, thereby down-regulating their expression of
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VEGFR-2. This process of lateral inhibition, with cells battling to
inhibit each other leads eventually to a ‘‘salt and pepper’’
alternating pattern, where cells with high Dll4 levels remain with
high VEGFR-2 receptor levels, allowing them to migrate (and
becoming tip cells) whilst their neighbors become inhibited,
making them less susceptible to VEGF, and thus these adopt the
non-migratory stalk cell phenotype. In this manner the adequate
amount of tip cells, required for a correct sprouting pattern, is
established [2–5].
Multiscale models of angiogenesis
Both fracture healing as well as angiogenesis are very complex
biological processes involving the coordinated action of many
different cell types, biochemical and mechanical factors across
multiple temporal and spatial scales. The time scales of individual
events that underlie biological processes range from seconds for
phosphorylation events to hours for mRNA transcription to weeks
for tissue formation and remodeling processes [6]. The spatial
scales vary from nanometers at the molecular level to millimeters
at the tissue level and meters at the level of the organism [6,7].
Thus, it can be concluded that most biological processes have an
intrinsic multiscale nature and must be studied and modeled
accordingly.
Depending on the biological spatial scale of interest a variety of
experimental and modeling approaches can be used, which are
nicely summarized by Meier-Schellersheim et al. [7]. The
modeling approaches can be arranged in two broad categories:
continuum and discrete modeling techniques. Continuum models
use ordinary differential equations (ODEs) or partial differential
equations (PDEs) to describe the evolution of cell and tissue
densities and protein concentrations. The model variables are
averages, which makes it difficult to represent individual cell-cell
and cell-matrix interactions [8,9]. Moreover, since the cells are
not individually represented, it is challenging to model the
individual intracellular processes. Also, continuum models fail to
correctly capture the process of angiogenesis due to the inherent
discreteness of vascular networks [10]. Discrete approaches are
often used to study small-scale phenomena, e.g. biological
processes at the cellular and subcellular levels [11]. However,
these techniques often become computationally expensive when
used for predictions of larger cell population sizes at the tissue scale
[11].
Here we briefly review hybrid, multiscale models of angiogen-
esis, i.e. models that combine different modeling techniques for
various scales mentioned above into one framework, as this is the
approach we have adopted here. For comprehensive reviews on
(multiscale) mathematical models of angiogenesis the reader is
referred to Mantzaris et al., Qutub et al. and Peirce [12–14].
Notably none of the hybrid models to date include Dll4-Notch1 tip
cell selection.
Milde et al. presented a deterministic hybrid model of sprouting
angiogenesis where a continuum description of VEGF, MMPs,
fibronectin and endothelial stalk cell density is combined with a
discrete, agent-based particle representation for the tip cells [15].
The hybrid model describes the biological process of sprouting as
the division of tip cells depending on chemo- and haptotactic cues
in the environment and a phenomenological ‘‘sprout threshold
age’’. In the model of Lemon et al. the formation of a new branch
also occurs at the tip cell position, but is modeled as a random
process with an average number of branches per unit length of the
capillary [16]. Checa et al. model sprout formation stochastically
by making the probability of sprouting from a vessel segment
proportional to the segment length. The capillary growth rate is
also regulated by the local mechanical stimulus [17]. Peiffer et al.
proposed a hybrid bioregulatory model of angiogenesis during
bone fracture healing [18], based on the deterministic hybrid
model of Sun et al. [19]. The process of angiogenesis is modeled
discretely, including sprouting and anastomosis. The selection of
tip cells in the growing vascular network is, however, modeled with
phenomenological rules. A three dimensional model of cellular
sprouting at the onset of angiogenesis was developed by Qutub et
al. [20]. Although this framework describes sprout formation as a
function of the local VEGF concentration and the presence of
Dll4, it is only a first approximation of the complex tip-to-stalk cell
communication by Dll4/Notch signaling.
A more detailed model of the lateral inhibition that underlies
the tip cell selection process in angiogenic sprout initialization was
presented by Bentley et al. [3,21]. They use an agent-based
framework to accurately simulate a small capillary comprising 10
endothelial cells that can change shape and sense the local VEGF
concentration by extending very thin filopodia. Moreover, every
endothelial cell is characterized by its individual protein levels of
VEGFR-2, Dll4 and Notch – and their distribution on the cell
membrane, by further subdividing the membrane into separate
agents – which does not only allow assessment of the effects of the
VEGF environment on tip/stalk cell patterning but also those of
Dll4 over- and under-expression and cell shape change.
Sprouting angiogenesis involves multiple biological scales: the
intracellular scale where gene expression is altered so that different
phenotypes (e.g. tip and stalk cells) can arise, the cellular scale that
involves proliferation and migration and the tissue scale that
encompasses the concentration fields of soluble and insoluble
biochemical factors. As these scales are highly coupled, multiscale
models are needed to study the mechanisms of sprouting
angiogenesis. To the best of the authors’ knowledge, there is only
one model of sprouting angiogenesis with Dll4-Notch1 rigorously
implemented [3] but this model simplified the extracellular
environment to a uniform or linearly varying field of VEGF
concentration, which is constant in time. While this simplification
is justified for a detailed study of the short term phenotypic
Author Summary
The healing of a fracture largely depends on the
development of a new blood vessel network (angiogen-
esis), which can be investigated and simulated with
mathematical models. The current mathematical models
of angiogenesis during fracture healing do not, however,
implement all relevant biological scales (e.g. a tissue,
cellular and intracellular level) rigorously in a multiscale
framework. This study established a novel multiscale
platform of angiogenesis during fracture healing (called
MOSAIC) which allowed us to investigate the interactions
of several influential factors across the different biological
scales. We focused on the biological process of tip cell
selection, during which a specific cell of a blood vessel, the
‘‘tip cell’’, is selected to migrate away from the original
vessel and lead the new branch. After showing that the
MOSAIC model is able to correctly predict the bone
regeneration process as well as many experimentally
observed aspects of tip cell selection, we have used the
model to investigate the influence of stimulating signals
on the development of the vasculature and the progres-
sion of healing. These results raised an important
biological question concerning the criterion for tip cell
selection. This study demonstrates the potential of multi-
scale modeling to contribute to the understanding of
biological processes like angiogenesis.
A Multiscale Model of Sprouting Angiogenesis
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changes of a few neighboring endothelial cells, it is not for more
complex, multicellular systems that involve cell-matrix interaction
and highly dynamic, extracellular environments. This is certainly
true for fracture healing, in which matrix densities and (gradients
of) extracellular concentrations of soluble signals, like VEGF, are
spatially and temporally changing as a result of cellular activity.
While efforts have been done to model the interplay of VEGF
diffusion and sprouting angiogenesis in the context of skeletal
muscle tissue [6], these multiscale models did not incorporate Dll4-
Notch1 signaling. Moreover, in the context of fracture repair
multiscale models that consider angiogenesis and that relate tissue,
cell and intracellular scales have not been established yet [22].
Objectives of this study
In this study, we present a multiscale model of osteogenesis and
sprouting angiogenesis with lateral inhibition of endothelial cells
(MOSAIC) which extends the bioregulatory framework of Peiffer
et al. [18] with an intracellular model based on the work of Bentley
et al. on tip cell selection [3]. We hypothesize that the MOSAIC
model creates enhanced capabilities for investigating the influence
of molecular mechanisms on angiogenesis and its relation to bone
formation. Simulation results will illustrate the interplay between
molecular signals, in particular VEGF, Dll4 and Notch1,
endothelial cell phenotypic behavior and bone formation. They
will demonstrate the advantages of multiscale modeling in the
context of fracture healing, thereby exploring the importance of
the model of Bentley et al. [3] for a much more complex and
dynamic extracellular environment. At the same time, by
comparison to the more phenomenological model of Peiffer
et al. [18] the potential of a more mechanistic treatment of tip cell
selection will become clear.
Methods
The MOSAIC model presented in this work integrates an
intracellular module based on the work of Bentley et al. [3] into
the model of Peiffer et al. [18]. Figure 1 gives a schematic overview
of the MOSAIC model which consists of (1) a tissue level
describing the various key processes of bone regeneration with
continuous variables, (2) a cellular level representing the develop-
ing vasculature with discrete endothelial cells and (3) the
intracellular level that defines the internal dynamics of every
endothelial cell. The combination of continuous and discrete
modeling techniques results in a hybrid, multiscale model.
Discrete description of angiogenesis
The discrete variable cv represents the blood vessel network,
which is implemented on a lattice. When a grid volume contains
an endothelial cell this variable is set to 1, otherwise cv=0. The
vessel diameter is defined by the grid resolution and is always one
endothelial cell wide, although the movement of the tip cell is grid
independent as explained below. Every endothelial cell (cv=1) has
unique intracellular protein levels, which control the behavior of
that specific cell. The intracellular module is adapted from the
agent-based model of Bentley et al. [3] and consists of the
following variables: the level of VEGFR-2 (V), Notch1 (N), Dll4
(D), active VEGFR-2 (V9), active Notch1 (N9), effective active
VEGFR-2 (V0), effective active Notch1 (N0) and the amount of
actin (A). The effective active levels (V0 and N0) include the time
Figure 1. Schematic overview of the multiscale model and a flowchart of its numerical implementation. (A) Scale separation map
indicating schematically the modeled processes at different spatial and temporal scales. Intracellular variables are further explained in Table 1 and
govern endothelial cell (EC) behavior. Cell types that are considered at the tissue scale (MSCs: mesenchymal stem cells, CHs: chondrocytes, OBs:
osteoblasts, FBs: fibroblasts) can migrate (only MSCs and FBs), proliferate (circular arrows), differentiate (vertical arrows) and produce growth factors
(gb: osteogenic growth factor concentration, gc: chondrogenic growth factor concentration, gv: angiogenic growth factor concentration) and
extracellular matrix (mf: fibrous tissue density, mb: bone density, mc: cartilage density, m: total tissue density). Blood vessels serve as an oxygen
source (n: oxygen concentration). Variables next to an arrow indicate their mediating role for a certain tissue level process. (B) Flowchart of the
numerical implementation of the MOSAIC model ( c!(t): vector of the continuous variables, t: time, dt: time step of the inner loop, Dt: time step of the
outer loop, cv: endothelial cells).
doi:10.1371/journal.pcbi.1002724.g001
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delay of translocation to the nucleus, thereby representing the
levels at the nucleus, influencing gene expression. The amount of
actin (A) refers to the polymerized actin levels (F-actin) inside the
cell. In particular, it is associated to actin used for filopodia
formation, owing to its importance for tip cell migration. As such,
an increase in actin levels can be interpreted as filopodia
extension, while a decrease as filopodia retraction. Other
intracellular signaling pathways that involve actin, such as energy
metabolism [23,24], are not considered.
The following equations describe the intracellular dynamics. An
overview of all the parameters of the intracellular module can be
found in Table 1.






where the constant Vsink represents the amount of VEGFR-1
receptors that act as a sink (decoy receptor) by removing VEGF
from the system, t represents the time and dt the time step of the
inner loop (more information on these parameters can be found in
the section ‘‘implementation details’’ below), Vmax represents the
maximal amount of VEGFR-2 receptors, gv is the local VEGF
concentration (at the tissue level) and Mtot is the total number of
membrane agents (constant for all ECs). Equation 1 is adapted
from Bentley et al. [3] where every EC is composed of a varying
amount of membrane agents, representing small sections of the
cellular membrane. In the current framework, however, every EC
is represented by one agent so that Mtot was chosen to be constant
for all ECs and equal to an intermediate value between the initial
and maximal amount of membrane agents in the agent-based
framework of Bentley et al. [3]. The level of activated VEGFR-2
remains in a range going from 0 to V. When the VEGFR-2
receptors are activated above a certain threshold (V9*), the actin
levels of the endothelial cell are incremented in a constant manner
(DA). As mentioned earlier, this represents the extension of
filopodia by the endothelial cell, which is shown to be regulated
downstream of VEGFR-2 [4]. If the endothelial cell fails to extend
its filopodia for a certain amount of time D3, the filopodia retract
which is mathematically translated into a reduction of the actin
levels in a constant manner (210.DA). The actin level remains in a
range between 0 and Amax. The amount of Notch1 is considered to
be constant in every EC, representing a balance between the rate
of degradation and expression. At the same time, initial Notch
activity levels are assumed to be zero and in the model Notch
activity can only be increased through binding with Dll4 from
neighboring ECs. The model therefore neglects the role of Notch
in EC quiescence and the fact that high Notch activity levels have
been measured in quiescent ECs [25–27]. Instead, it only focuses
on the role of Dll4-Notch in tip cell selection. The number of
activated Notch receptors (N9) will be equal to the total amount of
Dll4 available (with an upper bound, given by the total number of
Notch receptors N). The amount of Dll4 in the environment of an
EC is the sum of the amount of Dll4 at the junctions with its
neighboring ECs, whereby every cell is assumed to distribute Dll4
uniformly across its cell-cell junctions (see Figure 2).
After a delay of D1 for V9 and D2 for N9 the active VEGFR-2
and Notch levels become the effective active levels (V0 and N0)
representing the levels at the nucleus, influencing gene expression.
The delays were taken from Bentley et al. which were fitted to a
somite clock Delta-Notch system [3,28]. Note that there is a delay
between receptor activation and gene expression (transcription)
but not between gene expression and protein synthesis (transla-
tion), which is a simplification of the model.
The amount of Dll4 is modeled in the following way:
Dt~Dt{dtzV ’’t{dt:d{N ’t{dt,neighbours ð2Þ
Dt{dt represents the previous amount of Dll4, d the change in Dll4
expression due to the activation of the VEGFR-2 receptor [4,29]
and N ’t{dt,neighbours is the amount of Dll4 that is removed from the
Table 1. Parameter values of EC state variables.
Parameter Definition Setting
Mtot number of membrane agents per EC 1500
Vmax maximal amount of VEGFR-2 receptors 115000
Vmin minimal amount of VEGFR-2 receptors 2500
N amount of Notch receptors (constant) 25000
Dmax maximal amount of Dll4 25000
Amax maximal amount of actin 5000
Vsink proportion of VEGF left by VEGFR-1 0.275
s VEGFR-2 expression change due to Notch1 47.40
V9* threshold of active VEGFR-2 for actin production and migration of tip cells 200
A* threshold of actin for tip cell selection 3500
V* threshold of VEGFR-2 for tip cell selection Vmax/2
DA constant increment of actin 50
D1 delay between active and effective active VEGFR-2 levels 3.dt
D2 delay between active and effective active Notch levels 3.dt
D3 inactive time before retraction of filopodia 3.dt
ee maximal time step of inner loop 1.2 h
row maximal time step of outer loop 8.57 h
doi:10.1371/journal.pcbi.1002724.t001
A Multiscale Model of Sprouting Angiogenesis
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environment due to the activation of Notch-receptors on
neighboring ECs. If-conditions are used to ensure that the Dll4
level remains in a range between 0 and Dmax. When Notch
signaling is activated in a cell, the amount of VEGFR-2 receptors
is down-regulated, suppressing the tip cell phenotype as follows
[4,5]:
Vt~Vmax{N ’’t{dt:s ð3Þ
Vmax represents the maximal amount of VEGFR-2 receptors and s
models the VEGFR-2 expression change due to Notch1 activa-
tion. If-conditions are used to ensure that the VEGFR-2 level
remains in a range going from Vmin to Vmax. Since the amount of
VEGFR-2 (V) at the previous timestep (Vt{dt) is not present in
Equation 3, the amount of VEGFR-2 is continuously in
equilibrium with the amount of effective active Notch1 (N ’’t{dt).
Equation 3 implies that in quiescent cells the number of VEGFR-2
receptors will be maximal, owing to the absence of any Notch
activity. As mentioned earlier, the model neglects the role of Notch
activity in quiescence and the fact that it will lead to reduced
VEGFR-2 levels in quiescent ECs [25–27].
Note that Bentley et al. [3] represent every EC by a varying
number of agents (to account for changes in cell shape and cell
growth), whereas in this study every EC is represented by one
agent. However, in order to use the parameter values and
equations (in an adapted form) of Bentley et al. [3], Mtot was fixed
at a constant value for all ECs. Consequently, the values of V, N,
V9, N9, V0, N0, D and A are evaluated at the cellular level, not at the
level of individual membrane agents. This also implies that here
cellular polarity is not captured explicitly as receptor and ligand
concentrations are uniformly distributed across the membrane
junctions. In the current model cell directional behavior follows
from gradients of extracellular signals alone.
The evolution of the vascular network is determined by tip cell
movement, sprouting and anastomosis [18,19], outlined below.
Tip cell movement. The model computes the movement of
every tip cell in a lattice-free manner. The cells that trail behind
this tip are subsequently considered to be endothelial cells.
Consequently, although the movement of a tip cell is grid
independent, the vessel diameter is defined by the grid resolution
due to the projection of the blood vessels on the grid. The
movement of the tip cells is determined by their direction and












! represents the position, vtip the speed and utip! the
direction of movement of the tip cell. The tip cell speed depends
on the active VEGFR-2 concentration, meaning that both the
surrounding VEGF concentration as well as the amount of VEGF-
receptors influences the behavior of the tip cell [4,30]. Below a
threshold activation level (V9*) the tip cells do not migrate, above
this, the tip cell velocity increases with V9 up to a maximal speed of
vmaxtip . This translates into the following equation, where a third
order polynomial was used to ensure a smooth threshold [18]:
vtip~
0 if V ’vV ’
vmaxtip
V 03
V 03zV 03 if V ’§V ’
(
ð5Þ
The direction of movement is influenced by chemotactic and
haptotactic signals and is modeled in the same way as Peiffer et al.
[18].
Sprouting. The tip cell phenotype is induced (formation of a
new branch) or maintained (in already existing tip cells) if the





This criterion means that the endothelial cell must have enough
VEGFR-2 and filopodia (polymerized actin) to sense the
environment and direct the trailing branch towards the source
of VEGF.
Anastomosis. When a tip cell encounters another blood
vessel anastomosis takes place, after which the EC loses its tip cell
phenotype.
Evolution of the continuous variables
At the tissue level, the fracture healing process is described as a
spatiotemporal variation of eleven continuous variables: mesen-
chymal stem cell density (cm), fibroblast density (cf), chondrocyte
density (cc), osteoblast density (cb), fibrous extracellular matrix
density (mf), cartilaginous matrix density (mc), bone extracellular
matrix density (mb), generic osteogenic growth factor concentration
(gb), chondrogenic growth factor concentration (gc), vascular growth
factor concentration (gv) and concentration of oxygen (n). The set
of partial differential equations (PDEs) accounts for various key
processes of bone regeneration. Initially the callus is filled with
granulation tissue and the mesenchymal stem cells and growth
factors will quickly occupy the regeneration zone. Subsequently
the mesenchymal stem cells differentiate into osteoblasts (intra-
membranous ossification – close to the cortex away from the
fracture site) and chondrocytes (central callus region). This is
followed by VEGF expression by (hypertrophic) chondrocytes,
which attracts blood vessels and osteoblasts and which is
Figure 2. Conceptual representation of the Dll4 distribution
across the cell membranes of endothelial cells. The dark grey ECs
represent the original branch whereas Ti and Si are part of a newly
formed sprout (T = tip cell, S = stalk cell). The amount of Dll4 was
arbitrarily chosen, a maximal amount of 25 000 ligands per EC (for an
EC with a length of 25 mm) was calculated by Bentley et al. [3],
estimated from Liu et al. [63].
doi:10.1371/journal.pcbi.1002724.g002
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accompanied by cartilage degradation and bone formation
(endochondral ossification). The model does not include bone
remodeling. The general structure of the set of continuous












where t represents time, ~x the space and ~cm(t,~x) the density of a
migrating cell type (mesenchymal stem cells and fibroblasts).~c(t,~x)
represents the vector of the other nine concentrations, ECM
densities, growth factor concentrations and oxygen concentrations
for which no directed migration is modeled. Dcm(~c) and D are the
diffusion coefficients. fi(~c) represents the taxis coefficients for both
chemotaxis and haptotaxis. f0(~cm,~c) and g(~cm,~c) are reaction terms
describing cell differentiation, proliferation and decay and matrix
and growth factor production and decay. Detailed information,
including the complete set of equations, boundary and initial
conditions, parameter values and implementation details can be
found in Peiffer et al. [18] and Geris et al. [31] and are provided
here as online supplement.
Implementation details
The partial differential equations are solved on a 2D grid with a
grid cell size of 25 mm. The width of the discrete ECs is determined by
the size of a grid cell (25 mm). Since the ECs in the model of Bentley
et al. [3] have a width of 10 mm, the parameter values taken from
Bentley et al. are multiplied with a factor of 2.5 (see Table 1). The
partial differential equations are spatially discretized using a finite
volume method assuring the mass conservation and nonnegativity of
the continous variables [32]. The resulting ODEs are solved using
ROWMAP, a ROW-code of order 4 with Krylov techniques for
large stiff ODEs [33]. The MOSAIC model is deterministic and
implemented in Matlab (The MathWorks, Natick, MA).
The flowchart in Figure 1B gives a schematic overview of the
computational algorithm used in this study. Firstly the continuous
variables are calculated. Then the inner loop is iterated which
consists of four subroutines: (1) the current tip cells are evaluated by
the tip cell selection criterion and, if necessary, they lose their tip cell
phenotype; (2) the new position of every tip cell is calculated using a
central difference scheme in space in combination with explicit
Euler time integration; (3) the code checks whether sprouting
occurs, meaning that other endothelial cells also satisfy the criterion
for tip cell selection; (4) the intracellular levels of every endothelial
cell are updated. Finally, the inner and outer loops are iterated until
the end time of the simulation is reached.
The outer loop has a maximal time step size of 8.57 hours (row).
Since the tip cells do not move more than one grid cell (25 mm) in
this time interval (vmaxtip =35 mm/day [19]), this maximal time step
size (row) implies that the 11 PDEs can be solved for a constant
vasculature. The inner loop has a maximal step size of 1.2 hours
(ee), similar to Peiffer et al. [18], and was chosen so that the
movement of the tip cells within one grid cell could be accurately
followed (ee%row). To reduce implementation difficulties, the time
step of the inner loop (dt) is determined by calculating how many
maximal inner loop time steps (ee) can fit in one outer loop time
step (DT) and dividing the outer loop time step by this number.
Consequently, the time step of the inner loop is not constant,
which means that D1, D2 and D3 vary slightly, but this is a minor
trade-off for the computational efficiency. Numerical convergence
tests have shown that the average inner time step dt is equal to
155 s. Consequently, D1, D2, D3 approximate the delays chosen by
Bentley et al. [3]. Since the time step dt is approximately 10 times
the time step of Bentley et al. [3], the parameter values of s and d
have been altered to match the dynamics of the Dll4-Notch
system. Numerical tests have shown that similar behavior is
retrieved when both s and d are multiplied with 3.16 (see Table 1).
Simulation details
Simulations were conducted using a quad-core IntelH XeonH
CPU with 12 GB RAM memory. Initially the callus domain is
filled with granulation tissue only (mf,init=10 mg/ml), all other
continuous variables are initialized to zero. Boundary conditions
Figure 3. Geometrical domain and boundary conditions. (left) Geometrical domain deduced from the real callus geometry at postfracture
week 3 [35]; 1 periosteal callus; 2 intercortical callus; 3 endosteal callus; 4 cortical bone. (right) Boundary conditions. The mesenchymal stem cells (cm)
and fibroblasts (cf) are released from the periosteum, the surrounding soft tissues and the bone marrow [64]. The chondrogenic growth factors (gc)
are released from the degrading bone ends [65] whereas the cortex is modeled to be the source of osteogenic growth factors (gb) [66]. cv indicates
the initial position of the ECs.
doi:10.1371/journal.pcbi.1002724.g003
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are presented in Figure 3. Further information on the choice of
appropriate boundary and initial conditions of the continuous
variables can be found in Peiffer et al. [18] and Geris et al. [31].
Normal fracture healing. The initial values of the endothe-
lial cell variables are summarized in Table 2. The EC starting
positions are depicted in Figure 3.
Impaired angiogenesis. The influence of very high VEGF
concentrations on tip/stalk cell patterning and angiogenesis was
investigated by including an additional, constant source term
(constant production rate) in the equation for gv. This term was
varied between 0% and 10% of the default production rate (Ggvc since
the chondrocytes dominate the angiogenic growth factor production;
see supplementary material for the explanation of the meaning of Ggvc)
representing normal and very high VEGF concentrations in the callus
respectively. The effect of the injection of VEGF-antibodies, described
by an additional sink term in the equation for gv, was also simulated
[34]. The sink term was defined in such a way that no more VEGF
than present could be removed thereby ensuring that the VEGF
concentration stays positive. The effect of pharmacological inhibition
of the VEGFR-2 receptor was investigated by setting V9 to zero.
Sensitivity analysis. As Peiffer et al. [18] already performed
extensive sensitivity analyses additional sensitivity analyses focused
on the parameters related to the newly implemented tip cell
selection mechanism (i.e. s, d, V9*, Vsink). Experimental observa-
tions indicate that heterozygous Dll4 knockout mice still have
some Notch activity but produce too many tip cells due to the
lowered inhibition levels [5]. The MOSAIC model was used to
simulate various genotypes corresponding to different expression
levels of Dll4. The parameter d, which defines the Dll4 expression
change due to VEGFR-2 activation, was varied between 50% and
200%, representing a heterozygous knockout genotype and
overexpression respectively [3]. The parameter s, which repre-
sents the influence of the VEGFR-2 expression change due to
Notch1, was also varied, between 33% and 133%. The threshold
of active VEGFR-2 for actin production and migration of tip cells
(V9*) was varied between 25% and 1000%. The amount of
VEGFR-1 acting as a decoy receptor was changed by reducing
Vsink from 0.9% to 364%. The effect of the initial values of Dll4
(D0) and actin (A0) was also investigated, the initial amount of Dll4
was varied between Dmin and Dmax and the initial amount of actin
was varied between 0% and 100%.
Results
Normal fracture healing
The MOSAIC model predicts the evolution of the continuous
variables as well as the evolution of the intracellular variables
during normal fracture healing. The osteoprogenitor cells enter
the callus from the surrounding tissues and differentiate into
osteoblasts under the influence of osteogenic growth factors. This
leads to rapid intramembranous ossification near the cortex and
distant from the fracture line. In the endosteal and intercortical
callus the bone is formed through the endochondral pathway,
starting from a cartilage template that is mineralized as the blood
vessel network is formed to supply the complete fracture zone with
oxygen. Figure 4 compares the predictions of the Peiffer-model
[18] and the MOSAIC model with the experimentally measured
tissue fractions of Harrison et al. in a rodent standardized fracture
model [35]. Both models capture the general trends in the
experimental data equally well: the bone tissue fraction gradually
increases throughout the healing process; the fibrous tissue fraction
disappears; the cartilage template is first produced and later
replaced by bone.
After one, two and three weeks of simulated healing time the
surface fraction of the blood vessels in the callus is respectively
2.34%, 18.20% and 46.25%. Experimental results also show that
the vascular plexus is very dense in the fracture callus, although
quantitative results are lacking [36,37]. Images, illustrating the
angiogenic and osteogenic process in the fracture callus can be
found in Maes et al. and Lu et al. [38,39]. These experimental
studies report that at the progressing front, there is a tree-like
structure of tip cells extending filopodia to sense their environment
and to guide the developing sprout. At the back, the vasculature is
being remodeled into a more structured network of larger vessels
with more quiescent endothelial cells. At present this remodeling
phase of the vasculature, which will remove some blunt ends as
well as redundant vessels, is not included in the MOSAIC model.
Figure 5 shows that the tip cells have high VEGFR-2 levels. The
stalk cells are inhibited and have low VEGFR-2 and actin levels.
The Dll4-Notch signaling stops when the VEGF-concentration in
the callus drops (the VEGFR-2 levels stay constant) (Equations 1–
3). The VEGF concentration goes down since the vasculature
brings enough oxygen to the fracture site. The endothelial cells far
away from the vascular front all have maximal VEGFR-2 levels.
The average VEGFR-2 concentration, predicted across all ECs
present in the fracture callus, drops at day 7 in the standard
condition (Figure 6, standard). Indeed, after 7 days the ECs start to
inhibit each other in gaining the tip cell phenotype, resulting in a
prediction of enhanced Notch1-signaling and reduction of the
average VEGFR-2 levels at the vascular front. At the back,
VEGFR-2 levels are predicted to return to their maximal value,
which is a direct consequence of Equation 3 (effect of Notch
activity on VEFGR-2), and the fact that in the model Notch
activity levels of an EC are only governed by VEGF-induced Dll4
expression (in its neighboring cells). As mentioned before, the
model only focuses on the lateral inhibition between tip cells and
stalk cells through Dll4-Notch. It does not address EC quiescence
and the fact that Notch activity in quiescent ECs will be associated
with reduced VEGFR-2 receptor levels [25–27]. Despite this
anomaly in terms of the number of VEGFR-2 receptors, the
model correctly predicts highly reduced VEGFR-2 activity levels
in quiescent cells (i.e. cells at the back of the vasculature), because
of the low VEGF concentrations encountered here. This trend in
the average VEGFR-2 concentration (Figure 6, standard) was also
measured by Reumann et al. [40]. Reumann et al. characterized
the time course of VEGFR-2 mRNA expression during endo-
chondral bone formation in a mouse rib fracture model by
quantitative RT-PCR [40]. They observed a small drop (although
statistically insignificant) in the median value of VEGFR-2 mRNA
expression at three days post fracture [40]. The simulated average
VEGFR-2 concentration (Figure 6, standard) follows a similar
Table 2. Initial values of EC state variables.
Variable Definition Setting
V level of VEGFR-2 Vmax
N level of Notch1 N
D level of Dll4 0
V9 level of active VEGFR-2 0
N9 level of active Notch1 0
V0 level of effective active VEGFR-2 0
N0 level of effective active Notch1 0
A level of actin 5000
doi:10.1371/journal.pcbi.1002724.t002
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trend but drops at later time points (day 7 versus day 3). The
experimental results [40] were, however, determined in a mouse
rib fracture model whereas the parameter values of the model
presented in this study were derived from a rat femur fracture
model [35]. At the same time, it should be mentioned that Figure 6
represents protein values where Reumann et al. [40] measured
mRNA levels. Moreover, Reumann et al. [40] measured the total
mRNA content, of all cells present in the callus whereas Figure 6
shows the average VEGFR-2 concentration on the cell mem-
branes of the ECs in the callus. Not only ECs but also osteoblasts
and other osteogenic cells express VEGFR-2 [41], which might
also explain the temporal difference seen between the experimen-
tal and simulated data.
Impaired angiogenesis
If pharmacological blocking of VEGFR-2 receptors is simulat-
ed, the vasculature does not develop since the actin production is
inhibited, meaning that the ECs cannot extend filopodia and gain
the tip cell phenotype. Due to this impaired vascularization only a
small amount of bone is predicted intramembranously, resulting in
a non-union between the fractured bone ends.
If the VEGF concentration is increased (Figure 7B), the vascular
density is initially increased since the VEGFR-2 receptors are
being more activated in this stimulating environment (Equation 1).
This simulation result is confirmed by many experimental studies
that reported an increase in vascularity at the site of VEGF
application in a murine femoral fracture healing model [34], a
lapine mandibular defect model [42], a murine ectopic model [43]
and a rat femoral bone drilling defect model [44]. In the
simulations the increase in vascular density leads to faster healing,
which is also found experimentally [34,42] (Figure 8). The
MOSAIC model predicts earlier bone formation, less cartilage
formation in both the periosteal, intercortical as well as the
endosteal callus. Moreover, the cartilage resorption is predicted to
Figure 4. In silico and in vivo evolution of normal fracture healing. Temporal evolution of the bone, cartilage and fibrous tissue fractions (%) in
the periosteal, intercortical and endosteal callus as predicted using the hybrid model of Peiffer et al. [18] and the newly developed multiscale model
and as measured by Harrison et al. [35].
doi:10.1371/journal.pcbi.1002724.g004
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Figure 5. Image of the amount of VEGFR-2 per EC for different Dll4 expression and Notch activity levels at post fracture day 19. The
figure is focused on the periosteal callus (area 1 in Figure 3). Remark that the tip cells have a lot of VEGFR-2 (dark brown) whereas the following stalk
cells are inhibited, giving rise to a low number of VEGFR-2 (dark blue). (A) Influence of Dll4 levels. (B) Influence of Notch1 activity levels. Left:
heterozygous knockout, middle: standard condition, right: overexpression.
doi:10.1371/journal.pcbi.1002724.g005
Figure 6. Temporal evolution of the average amount of VEGFR-2 on ECs in the callus for different levels of VEGF addition
(corresponding to Figure 7B). Evolution of the average VEGFR-2 concentration (day 0 corresponds to the time of fracture). The threshold line
represents the first requirement that needs to be fulfilled to obtain the tip cell phenotype, i.e. V.Vmax/2. Remark that in very high VEGF
concentrations (+10%) the average receptor concentration is far below the threshold.
doi:10.1371/journal.pcbi.1002724.g006
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be accelerated, another trend which has been reported in
experimental studies [43,44]. It is striking, however, that after 35
days, the MOSAIC model predicts that the VEGF-treated callus
contains slightly less bone and more remnants of fibrous tissue
than the normal condition (Figure 8).
A further increase of the VEGF concentration (+2%,
Figure 7B(iii)) reduces however the vascular density and bone
tissue fraction in the MOSAIC model. This is consistent with the
trend seen by Street et al., where an optimal dose of VEGF
(250 mg) leads to a maximal amount of callus volume (both total
and calcified) in a critical rabbit radius segmental gap model [34].
In higher VEGF environments (e.g. Figure 7B(iii)) the ECs
strongly inhibit each other; creating a salt and pepper pattern of
high and low VEGFR-2 levels (Figure 9). In addition, the
development of the vasculature ceases after a certain period, as
can be seen in Figure 9. The ECs that fulfill the tip cell criteria
(Equation 6) will sprout and will initially move perpendicular to
the vessel from which it is originating. In case this ‘‘mother’’ vessel
is a growing vessel as well that extends towards the source of the
chemotactic and haptotactic signals, this implies that the new
sprout will initially move perpendicular to the gradients. In this
particular configuration (Figure 7B(iii)), the vascular front was
Figure 7. Vasculature at 35 days post fracture for different conditions. (A) Variation in the amount of the decoy receptor VEGFR-1 (i:
Vsink= 100% (standard condition), ii: Vsink=45%, iii: Vsink=9%, iv: Vsink= 0.9%); (B) Variation in the amount of VEGF addition in the multiscale model
with the standard tip cell selection criterion (based on V; Equation 6) (i: 0% (standard condition), ii: 0.1%, iii: 2%, iv: 10%); (C) Variation in the amount
of VEGF addition in the multiscale model with an altered tip cell selection criterion (based on V9) (i: 0%, ii: 0.1%, iii: 2%, iv: 10%); (D) Variation in the
amount of VEGF addition in the hybrid model (i: 0%, ii: 0.1%, iii: 2%, iv: 10%).
doi:10.1371/journal.pcbi.1002724.g007
Figure 8. In silico evolution of fracture healing for various conditions. Temporal evolution of the bone, cartilage and fibrous tissue fractions
(%) in the periosteal, intercortical and endosteal callus as predicted by the MOSAIC model. (full: normal fracture healing; dashed: Dll4 overexpression
(d= 12.64, Figure 5A); dotted: VEGF-addition (+ 0.1%, Figure 7Bii).
doi:10.1371/journal.pcbi.1002724.g008
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progressing in a more ‘‘sheet-like’’ fashion. Consequently, the tip
cells persistently want to sprout towards already occupied grid
cells, an action that is not allowed in the computational
framework. The period after which the vascular development
ceases, is shorter in higher VEGF environments. Note that the
average VEGFR-2 concentration of all ECs in the callus reaches a
constant level which is reduced in high VEGF environments
(Figure 6).
When a reduction of VEGF concentration by means of the
addition of VEGF-antibodies is simulated, results demonstrate that
the VEGFR-2 receptor is not sufficiently stimulated. This leads to
an impaired vasculature and a non-union between the fractured
bone ends (see Table 3, Equation 1). The simulated reduction in
vascular density is consistent with the experimental findings of
Street et al. who incorporated a fracture hematoma supernatant
with neutralizing monoclonal antibody to human VEGF in a
Matrigel vehicle, which was then implanted in a murine dorsal
wound model [45]. There was a significant decrease in the number
of blood vessels formed in the Matrigel vehicle with neutralizing
monoclonal antibody when compared to the fracture hematoma
supernatant alone [45].
Sensitivity analysis
The sensitivity analysis indicates that the model results are
greatly influenced by the parameters s, d and Vsink and that the
MOSAIC model is insensitive to the initial conditions of Dll4 (D0)
and actin (A0). An overview of the results of the sensitivity analysis
can be found in Table 3.
Simulations of the heterozygous knockout genotypes (d=50%,
s=33%) show an increased sprouting due to a clearly reduced
inhibition of the tip cell phenotype (Equations 2–3). Figure 5
demonstrates that the endothelial cells behind the brown (tip) cells
with high VEGFR-2 levels are strongly inhibited in the normal
case but are weakly inhibited in the simulated knockout. The
overexpression of Dll4 (d=200%) increases the inhibition of the
tip cell phenotype resulting in a decrease of the vascular density
(Table 3) and a delay in the endochondral bone formation process,
particularly in the periosteal callus (Figure 8). The increase in s
also causes a more potent suppression of the tip cell phenotype in
the stalk cells, due to an increased down-regulation of VEGFR-2
by Notch1 (Equation 3). In turn, this leads to a decrease of the
vascular density (see Figure 5B, Table 3). Thus, if the tip cell
phenotype is more inhibited (by increasing d, which defines the
enhancement of Dll4 expression due to VEGFR-2 activation
(Equation 2) or increasing s, which represents the inhibition of the
VEGFR-2 expression due to Notch1 activation (Equation 3)), the
vascular density is reduced. This simulation result corresponds to
experimental observations [5,46,47]. Hellstro¨m et al. [5] showed
that the inhibition of Notch signaling (by inhibiting Notch receptor
cleavage and signaling with c-secretase inhibitors, by heterozygous
inactivation of the Notch ligand Dll4 or by endothelial cell specific
deletion of Notch1) promotes an increase in the number of tip cells
in the retina of newborn mice. Conversely, a 35% decrease in
filopodia density and a 45% decrease in vessel density were found
in a direct gain of function experiment of the Notch1 receptor.
Simulating an increase of the decoy receptor VEGFR-1 (by
decreasing Vsink) results in a reduction of the vascular density since
less VEGF remains available for VEGFR-2 activation (see
Figure 7A, Equation 1). This is consistent with Flt-1 (VEGFR-1)
loss- and gain-of-function data in zebrafish embryos [34,48].
Moreover, Street et al. showed that Flt-IgG treatment decreased
the vascularity by 18% and impaired cortical bone defect repair in
a murine femoral fracture healing model [34]. Similarly, the in
silico results show a delayed or even impaired healing of the
fracture due to the reduced vascular density. In Figure 7A(iv) the
VEGF concentration is too low to activate the VEGFR-2 receptors
which stops the angiogenic process. Since only a small amount of
bone will be formed intramembranously in the fracture callus of
Figure 7A(iv), the impaired vascularization will result in a non-
union.
If the threshold of VEGFR-2 activation V9*, below which the
actin production and tip cell movement is inhibited, is increased,
the vascular density decreases (see Table 3). The initial amount of
actin (A0) only slightly influences the final vascular density (see
Table 3). The other variables related to the fracture healing, were
not influenced. Similarly, the final vascular density is insensitive to
the initial intracellular amount of Dll4 (D0) (see Table 3).
Discussion
This study established a novel multiscale model of angiogenesis
in the context of fracture healing, by integrating an agent-based
Figure 9. Amount of VEGFR-2 receptors on every endothelial cell. (A) standard condition; (B) addition of 2% VEGF.
doi:10.1371/journal.pcbi.1002724.g009
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model of tip cell selection [3] into a previously developed hybrid
model of fracture healing [18]. The bone regeneration process was
predicted by the MOSAIC model in accordance with experimen-
tal reports and previously validated in silico results [18]. The
MOSAIC model was also able to capture many experimentally
observed aspects of tip cell selection: the salt and pepper pattern
seen in developing vascular structures under normal angiogenic
conditions, i.e. a tip cell with high VEGFR-2 and actin levels
followed by a stalk cell characterized by strong Notch1 signaling
and therefore reduced VEGFR-2 and actin levels [30], an
increased tip cell density and a higher vascular density in case of
Dll4 heterozygous knockouts [5] and an excessive number of tip
cells (leading to a very high vascular density) in high VEGF
concentrations [3,34]. The sensitivity analysis also indicated the
most influential parameters of the MOSAIC model (d, s and Vsink).
This study has addressed some, but not all of the limitations of
the Peiffer-model [18]. In the MOSAIC model the tip cell
selection is based on Dll4/Notch1 signaling whereas the Peiffer-






i.e. in the Peiffer-model the VEGF concentration needs to be high
enough (10 ng/ml), there needs to be a minimal separation of
100 mm between two tip cells and the movement direction of the
new tip cell should make an angle of .24u with the orientation of
its mother vessel. Moreover, the Peiffer-model foresees three
healing days between subsequent sprouting events, which has no
experimental foundation and has been removed in the MOSAIC
model. Consequently, the MOSAIC model is more mechanistic,
allowing investigation of different mutant and druggable cases in
the signaling pathways, leading to real predictions for experimen-
tation, which was not possible in the Peiffer-model. Since the
incorporation of the lateral inhibition mechanism leads to a denser
plexus in the MOSAIC model than in the Peiffer-model, we have
reduced the oxygen production rate by a factor of two so that the
final oxygen concentrations are the same in both models.
Experimental results show that the vascular plexus is indeed very
dense in the fracture callus [36,37].
In the MOSAIC model the tip cell velocity increases with the
active VEGFR-2 levels, indicating that both the level of VEGFR-2
and the external VEGF-concentration influence the tip cell speed.
This is consistent with the experimental data of Arima et al. [49].
They used time-lapse imaging in a murine aortic ring assay (with
and without VEGF) to quantify the behavior of the endothelial
cells during angiogenic morphogenesis [49]. Arima et al. reported
that VEGF-induced vessel elongation was only due to greater
displacement per tip cell [49]. Moreover, treatment with Dll4-
antibodies also resulted in a greater displacement per tip cell [49].
This is due to the reduced inhibitory actions of Dll4, causing a
greater number of cells to have high VEGFR-2 levels. These
results are however contested by Jakobsson et al. who quantified
the average migration speed of wild-type (DsRed and YFP) and
heterozygous Vegfr2+/egfp endothelial cells in different chimaeric
embryoid bodies [50]. They observed no difference in migration
speed, indicating that VEGFR-2 levels do not determine EC
migration velocity [50]. Clearly, more research is necessary to
elucidate the above observations and improve the current
implementation of tip cell migration in future versions of the
model.
The MOSAIC model indicates a key role of the decoy receptor
VEGFR-1 (modeled via Vsink) (Equation 1). Increasing the amount
of VEGFR-1, results in a decrease of the vascular density
(Figure 7A) which is also seen in loss- and gain-of-function data
[34,48]. Both the MOSAIC model and the model of Bentley et al.
[3], use a constant value to represent the decoy-effect of the
VEGFR-1 receptor. There is however experimental evidence that
both VEGFR-1 and its soluble form are up-regulated in Notch-
activated stalk cells [4,51]. Hence, the stalk cells phenotype is not
only consolidated by a decrease in VEGFR-2 but also by an
increase in the competing VEGFR-1 receptor. The results of
Krueger et al. also suggest that VEGFR-1 regulates tip cell
formation in a Notch-dependent manner [48].
Table 3. Overview of the results of the sensitivity analysis.
Condition Week 1 Week 3 Week 5
standard 2.34% 46.25% 70.63%
s 33% 3.05% 56.25% 78.20%
100% 2.34% 46.25% 70.63%
133% 2.19% 45.00% 68.91%
d 50% 2.73% 54.92% 75.23%
100% 2.34% 46.25% 70.63%
200% 2.57% 37.66% 64.61%
Vsink 364% 5.00% 48.75% 70.08%
100% 2.34% 46.25% 70.63%
45% 0.63% 39.92% 67.11%
9% 0.63% 15.86% 37.03%
0.9% 0.63% 0.63% 0.63%
V9* 25% 3.20% 67.34% 76.64%
100% 2.34% 46.25% 70.63%
400% 0.63% 38.13% 56.56%
750% 0.63% 20.00% 51.25%
1000% 0.63% 15.16% 35.31%
A0 0% 2.42% 46.95% 72.73%
50% 2.42% 46.95% 72.73%
100% 2.34% 46.25% 70.63%
D0 0% 2.34% 46.25% 70.63%
28% 2.34% 46.25% 70.63%
64% 2.34% 46.25% 70.63%
100% 2.34% 46.25% 70.63%
VEGF
addition
0.1% 36.02% 76.09% 79.92%
2% 28.98% 54.22% 54.38%
2.4% 16.64% 16.64% 16.64%
10% 3.75% 3.75% 3.75%
VEGF
removal
21% 0.63% 10.70% 36.56%
21.5% 0.63% 4.84% 36.64%
23% 0.63% 0.78% 0.78%
25% 0.63% 0.63% 0.78%
The vascular density is measured at three time points post fracture (7, 21 and 35
days). In the standard condition the parameter values are s= 47.4, d=6.32,
Vsink= 0.275, V9*= 200, A0= 5000, D0= 0, which can also be found in Tables 1
and 2.
doi:10.1371/journal.pcbi.1002724.t003
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The MOSAIC model displays interesting behavior in high
VEGF environments (see Figure 7). Initially, the increase in VEGF
has a positive effect, resulting in a very dense vasculature since the
VEGFR-2 receptors are being more activated in this stimulating
environment (+0.1%; see Equation 1). This leads to a faster
healing, which is also found experimentally [34,42]. A further
increase (+2%), however, reduces the vascular density in the
MOSAIC model. This is consistent with the trend seen by Street et
al. [34]. Note that a salt and pepper pattern of high and low
VEGFR-2 levels is created and maintained in high VEGF
environments (+2%; Figure 7B(iii) and Figure 9). To explain this
observation, one needs to look at the beginning of the angiogenic
process in the fracture callus. Initially, some endothelial cells gain
the tip cell phenotype and start to migrate. Gradually sprouts arise
in the developing vasculature which increases the network size and
alters the local VEGF-levels due to the influence of the oxygen
tension on VEGF-production. The original tip cells maintain their
advantage (e.g. located in a higher VEGF environment) by
strongly inhibiting their neighboring ECs, creating a salt and
pepper pattern of VEGFR-2 levels. In standard conditions the
vasculature would start to mature, leading to quiescent ECs. In
high VEGF environments (+2%), however, this salt and pepper
pattern of VEGFR-2 is maintained (Figure 9), illustrating that
some ECs have (very) high VEGFR-2 levels leading to a persistent
inhibition of their neighboring ECs (characterized by low
VEGFR-2 levels). Figure 6 shows that these high VEGFR-2 levels
are cancelled out by the low VEGFR-2 levels resulting in a ‘‘steady
state’’ level of the average VEGFR-2 concentration. In high
VEGF environments (+2%, +10%) this ‘‘steady state’’ level is
gradually reduced (Figure 6), implying the dominance of the lower
VEGFR-2 levels. Mathematically, this result follows from Equa-
tions (1) and (3), indicating that in high VEGF concentrations both
the active VEGFR-2 (V9) and Notch (N9) (and with a delay the
effective active VEGFR-2 (V0) and Notch (N0)) are high, resulting
in a reduction of the VEGFR-2 receptor (Figure 10). Consequent-
ly, the average VEGFR-2 concentration is reduced below the
threshold for tip cell formation (Figure 6). In other words, the
majority of the ECs have too little VEGFR-2 receptors to assume
the tip cell phenotype. In the extreme case, this finally results in
the inhibition of the development of the vasculature since there are
no tip cells to lead the sprouts towards the VEGF source
(Figure 7B(iv)).
Interestingly, Figure 7D shows that similar results cannot be
obtained with the Peiffer-model [18], i.e. the vascular density is not
reduced in high VEGF environments (+2%, +10%). This is due to
the phenomenological rules that determine the tip cell selection in
the Peiffer-model (Equation 9). A similar ‘‘non-linear’’ EC
response to VEGF concentrations would only be possible with
the Peiffer-model if another phenomenological rule would be
implemented that e.g. down-regulates tip cell selection at high
VEGF responses. In contrast, the ‘‘non-linear’’ response follows
naturally from the mechanistic rules of tip cell selection that were
implemented in the MOSAIC model. That is, the down-regulation
of the tip cell selection in high VEGF environments (+2%, +10%)
arises from the negative feedback loop in the Notch-Dll4 signaling
pathway. Moreover, in high VEGF-environments (+10%) and at
the back of the developing vasculature, we see an indication that
patches of endothelial cells oscillate between cell fates (switching
between high and low VEGFR-2 levels). These patches are also
predicted by the model of Bentley et al. and are observed during
pathological angiogenesis [3]. In the future, we will further
investigate the conditions that give rise to these oscillations and
their implications on the development of the vasculature.
The results of the MOSAIC model are based on the assumption
that a tip cell phenotype can only be acquired if the levels of
VEGFR-2 and actin are sufficiently high (Equation 6). If this
criterion was changed by replacing the requirement on VEGFR-2
by a similar requirement for the level of active VEGFR-2, some
ECs could become tip cells, since V9 is high in high VEGF
environments (+2%, +10%), and the vasculature would fully
develop (Figure 7C). These results show the added value of the
MOSAIC model: the intracellular module and its related state
variables and rules decide on the EC response to the extracellular
VEGF environment, in turn determining the healing response at
the tissue level (Figure 8). In case the criterion for tip cell selection
is specified in terms of VEGFR-2 (and actin) the absence of blood
vessel formation will result in a non-union or a delayed union of
the fracture. However, when this criterion is replaced by one that
relies on the levels of active VEGFR-2 (and actin), a vascular and
healing response is retrieved, similar to the Peiffer-model.
Clearly, these findings give rise to some interesting biological
questions on a proper criterion for the tip cell phenotype. Since the
VEGFR-2 levels are strongly reduced in high VEGF environments
(+10%), the tip cells lose their tip cell phenotype and stop
migrating although there is a strong angiogenic signal present. Can
tip cells move in high VEGF environments although they do not
have enough VEGFR-2 receptors? If so, should the tip cell
criterion (Equation 6) be based on the active VEGFR-2 levels (V9),
since these remain high in high VEGF concentrations? Or is the
down-regulation of VEGFR-2 receptors in high VEGF environ-
ments compensated by other signaling cascades that have
VEGFR-2 as one of their downstream targets (leading to an
increase of VEGFR-2)?
In this study, the model of Peiffer et al. [18] was combined with
a detailed model of Dll4-Notch1 signaling [3]. Some simplifica-
tions were however made to the model of Bentley et al. due to
computational reasons, i.e. the size and shape of the ECs are fixed
in the PDE framework of the MOSAIC model. Consequently,
every EC is represented by one agent whereas Bentley et al. use a
varying amount of membrane agents for every EC [3]. This does
not only allow Bentley et al. to model the change in membrane
and cell shape in great detail, but also to include cellular polarity
(non-uniform distribution of receptors and ligands across the cell
membrane and cell-cell junctions). In the MOSAIC model,
filopodia extension is modeled implicitly by an increase in the
level of the ‘‘actin’’ variable upon VEGFR-2 activation. This is
consistent with current knowledge that activation of Cdc42 by
VEGF triggers filopodia formation [4]. Bentley et al. modelled
filopodia extension in more detail by adding membrane agents to
the cellular membrane. As a result, the number of VEGFR-2
receptors will alter due to filopodia extension, which is proposed to
Figure 10. Schematic representation of the Dll4-Notch pathway
in high VEGF environments for two neighboring ECs. Remark
that although the VEGFR-2 receptor is down-regulated, the VEGF
concentration is high enough to compensate for this effect resulting in
high V9 levels (Equation 1).
doi:10.1371/journal.pcbi.1002724.g010
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be a mechanism to consolidate the tip cell fate [3]. In the
MOSAIC model the accumulation of actin does not lead to an
increase in the amount of VEGFR-2 levels or to a change in the
microenvironmental range that can be probed by the tip cell.
However, if the molecular mechanisms of filopodia extension and
its implications on probing the environment and the directionality
of tip cell movement are clearer, these can be readily incorporated
in the multiscale framework.
The mechanism of lateral inhibition is based on Dll4/Notch1
signaling between the endothelial cells of the developing sprout.
Delta-Notch signaling is however an evolutionary conserved
pathway that is also involved in cell fate specification, tissue
patterning and morphogenesis [2,30,52,53]. In angiogenesis
specifically, Notch signaling influences endothelial cell specifica-
tion [4,5,30,54,55], endothelial proliferation [29,30], cell migra-
tion [2,30], filopodia formation [30], cell adhesion [30], and post-
angiogenic vessel remodeling and endothelial cell quiescence [56].
These effects are not only dependent on Dll4 and Notch1 but also
on the other ligands (Delta-like 1, Delta-like 3, Jagged-1 and
Jagged-2) and receptors (Notch2, Notch3 and Notch4) [57]. Due
to the complexity and interdependency of these pathways, only the
influence of Dll4-Notch1 signaling on tip cell selection was
modeled. Consequently, in the model once the VEGF levels are
reduced due to the restoration of the blood flow and tissue
oxygenation, the Dll4-Notch1 signaling pathway is not active
anymore. This is predicted to occur in the ECs that are located at
the back of the vasculature, returning their VEGFR-2 levels to the
maximal value. As mentioned before this contradicts the fact that
in quiescent cells VEGFR-2 levels will be minimal and smaller
than those of migrating cells, which is consistent with high Notch
activity in quiescence [25–27]. Since the MOSAIC model does not
include the role of Notch in quiescence, the simulation results are
only accurate for the initial formation of the vasculature and not
for the maturation and stabilization of the vascular plexus. This
does not, however, alter the main findings of this work concerning
sprouting angiogenesis.
Besides VEGFR-2, also other VEGF receptors, such as
VEGFR-1 and VEGFR-3 play a role in angiogenesis. Although
the VEGFR-3 receptor is mainly active in lymphangiogenesis,
recent experimental evidence indicates that VEGFR-3 is up-
regulated in tip cells during pathological angiogenesis [4,58].
Blocking this receptor reduces the amount of sprouting and EC
proliferation. It appears that VEGFR-2 induces VEGFR-3
expression in tip cells, whereas it is down-regulated in stalk cells
by Notch [4,59]. However, when more quantitative experimental
data become available on the role of VEGFR-1 and VEGFR-3 in
sprouting angiogenesis, this can be incorporated in the MOSAIC
model.
The MOSAIC model only focuses on soluble VEGF, whereas
VEGF-isoforms that bind to the extracellular matrix are essential
to establish the VEGF gradients required for guided tip cell
migration [60]. Some modeling work has already been done in this
area [61,62], e.g. Vempati et al. used a detailed molecular model
of VEGF ligand-receptor kinetics and transport to investigate the
VEGF-isoform specific spatial distributions observed experimen-
tally [61]. Many other factors, such as neuropilin 1 (NRP-1),
fibroblast growth factor (FGF), and platelet-derived growth factor
(PDGF) regulate the angiogenic response as well [2]. Nevertheless,
it has been stated repeatedly that VEGF is ‘‘the principal dancer’’
during angiogenesis [29,30].
The proposed MOSAIC model incorporates biological process-
es at various temporal and spatial scales: an intracellular module
that includes Dll4/Notch1 signaling to determine tip cell selection,
a discrete representation of the ECs allowing an accurate
representation of the developing vascular network and a contin-
uum description of oxygen, growth factors and tissues that finally
result in the healing of the fracture by the formation of bone. Our
simulation results demonstrate the advantages of such a multiscale
approach. Firstly, the interplay between molecular signals, in
particular VEGF, Dll4 and Notch1, endothelial cell phenotypic
behavior and bone formation was explored. In this way, the
MOSAIC model could be used to verify to what extent gene
knockouts, injection of VEGF-antibodies or blockage of VEGF-
receptors leads to a ‘‘bone phenotype’’ in terms of rate and
amount of bone formation (see e.g. Figure 8). While some of these
simulation results could be (qualitatively) compared to experimen-
tal data, it is clear that future research efforts must be focused on a
more comprehensive quantitative validation. Again, the multiscale
nature of the simulation results presents an advantage here, as it
allows for a validation at different scales (molecular, cellular and
tissue scale). Secondly, the proposed multiscale model is more
mechanistic since tip cell selection is based on intracellular
dynamics (Dll4-Notch1 signaling), rather than the phenomeno-
logical rules that were used in Peiffer et al. [18]. As such, the
MOSAIC model enabled to extend the model of Bentley et al. [3]
to the context of fracture healing, leading to interesting emergent
behavior at the macro-scale. More specifically, whereas the Peiffer-
model predicts the presence of a vascular network in high VEGF
environments (+10%) the MOSAIC model (depending on the tip
cell criterion) predicts the absence of a vascular network (see
Figure 7), which was a direct consequence of the Dll4-Notch
feedback mechanism (see explanation related to Figure 10). In
conclusion, the proposed multiscale method was found to be a
useful tool to investigate possible biological mechanisms across
different time and spatial scales, thereby contributing to the
fundamental knowledge of sprouting angiogenesis and its relation
to fracture healing.
Supporting Information
Text S1 This file contains a detailed description of the
mathematical model used in this study including the full set of
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